IRIS
RAIA, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.038
NA - Nord America 4.566
EU - Europa 4.356
SA - Sud America 834
AF - Africa 140
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.947
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.352
SG - Singapore 2.889
RU - Federazione Russa 2.068
CN - Cina 942
IT - Italia 837
BR - Brasile 686
HK - Hong Kong 511
VN - Vietnam 387
UA - Ucraina 259
DE - Germania 251
FI - Finlandia 230
NL - Olanda 201
GB - Regno Unito 144
CA - Canada 126
IE - Irlanda 99
SE - Svezia 69
IN - India 68
MX - Messico 62
AR - Argentina 57
PL - Polonia 46
FR - Francia 44
CI - Costa d'Avorio 37
ZA - Sudafrica 37
BD - Bangladesh 36
TR - Turchia 34
ES - Italia 27
JP - Giappone 25
CO - Colombia 24
ID - Indonesia 23
AT - Austria 21
EC - Ecuador 21
MA - Marocco 18
KR - Corea 16
LT - Lituania 16
PY - Paraguay 15
IQ - Iraq 14
IR - Iran 13
AE - Emirati Arabi Uniti 11
PK - Pakistan 11
CL - Cile 10
AU - Australia 9
UZ - Uzbekistan 8
BE - Belgio 7
PE - Perù 7
SA - Arabia Saudita 7
EG - Egitto 6
PA - Panama 6
RO - Romania 6
VE - Venezuela 6
AO - Angola 5
AZ - Azerbaigian 5
JO - Giordania 5
KE - Kenya 5
LB - Libano 5
MG - Madagascar 5
UY - Uruguay 5
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
TN - Tunisia 3
AM - Armenia 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
CD - Congo 2
DK - Danimarca 2
DM - Dominica 2
EU - Europa 2
GA - Gabon 2
GP - Guadalupe 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
BJ - Benin 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
IS - Islanda 1
LC - Santa Lucia 1
Totale 14.924
Salva come PNG Salva come JPEG
Città #
Singapore 1.263
Hong Kong 507
Chandler 501
Moscow 463
Ashburn 393
Beijing 325
Jacksonville 263
Santa Clara 229
Naples 211
Napoli 209
Millbury 171
Amsterdam 168
Los Angeles 159
Princeton 154
Ho Chi Minh City 132
Boston 130
Nanjing 91
New York 84
Munich 82
Wilmington 81
Hanoi 71
Buffalo 67
São Paulo 61
Redondo Beach 60
The Dalles 57
Ottawa 51
Houston 50
Hefei 43
Des Moines 42
Turku 41
Seattle 40
Dallas 36
Warsaw 36
Helsinki 34
Lawrence 30
Nanchang 30
Rome 30
Mexico City 29
Orem 29
Changsha 26
London 26
Shenyang 25
Toronto 25
Chennai 24
Chicago 24
Denver 24
Dong Ket 24
Tokyo 24
Montreal 23
Washington 22
Norwalk 21
Atlanta 20
Nuremberg 20
Phoenix 20
Brooklyn 19
Da Nang 19
Frankfurt am Main 19
Hebei 19
Poplar 19
Rio de Janeiro 18
Jiaxing 16
Johannesburg 16
Tianjin 16
Ankara 15
Belo Horizonte 15
Ninh Bình 15
Dhaka 14
Orange 14
Ribeirão Preto 14
Stockholm 14
Augusta 13
Biên Hòa 13
Falkenstein 13
Haiphong 13
Manchester 13
Boardman 12
Falls Church 12
Mugnano Di Napoli 12
Milan 11
Vienna 11
Querétaro 10
San Francisco 10
Woodbridge 10
Porto Alegre 9
Brasília 8
Charlotte 8
Quito 8
Salerno 8
Villaricca 8
Asunción 7
Bogotá 7
Casablanca 7
Caxias do Sul 7
Dublin 7
Guayaquil 7
Hangzhou 7
Kronberg 7
Oklahoma City 7
Redmond 7
Salvador 7
Totale 7.342
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 357
Clinical expression of patients with the D1152H CFTR mutation 148
TAS2R38 genotype and CRS severity in children with cystic fibrosis 146
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 142
Unexpected role of surface transglutaminase type II in celiac disease 140
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 135
Identification of Inquilinus limosus in Cystic Fibrosis: a first report in Italy 131
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 130
An investigation on parenting stress of children with cystic fibrosis 127
Diabetes in an infant with cystic fibrosis 125
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 125
Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects 125
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 121
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. 119
Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis 118
Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial. 118
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 118
Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? 116
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 115
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old. 115
Clinical expression of cystic fibrosis in a large cohort of Italian siblings 115
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. 112
Metabolic interactions between cysteamine and epigallocatechin gallate 111
Microbiology of airway disease in a cohort of patients with Cystic Fibrosis. 110
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition 110
Positive expiratory pressure treatment: efficacy in pulmonary diseases 109
Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. 108
Does virtual reality reduce pain in pediatric patients? A systematic review 108
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 107
Inhaled medications in cystic fibrosis beyond antibiotics 107
Chryseobacterium respiratory tract infections in patients with cystic fibrosis 106
Brand new SPINK1 and CFTR mutations in a child with acute recurrent pancreatitis: a case report. 106
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 106
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease 105
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. 104
Cystic fibrosis: a disorder with defective autophagy 104
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. 104
Pediatric ultrasonography of the pancreas: normal and abnormal findings 103
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease 102
Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis 102
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study 100
Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease. 100
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis. 100
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. 99
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 99
Salivary cytokines and airways disease severity in patients with cystic fibrosis 98
Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. 98
Different mutations in mucA gene of Pseudomonasaeruginosa mucoid strains in cystic fibrosispatients and their effect on algU gene expression 97
FAS engagement driver apoptosis of the enterocytes of coeliac patients 96
Towards a rational combination therapy of cystic fibrosis: How cystamine restores the stability of mutant CFTR 96
Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. 96
Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols 96
Effect of an 8-month treatment with omega-3 fatty acid (eicosapentanoic and docosahexaenoic) in patients with cystic fibrosis 95
One-year Glargine treatment can improve the course of lung disease in children and adolescents with Cystic Fibrosis and early glucose derangements 95
The ESPGHAN Cystic Fibrosis Working Group: defining DIOS and constipation in cystic fibrosis with a multicenter study on the incidence, characteristics, and treatment of DIOS. 95
Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. 95
The Multifaceted Roles of MicroRNAs in Cystic Fibrosis 95
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator 94
Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease 94
S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy 93
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. 92
Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis. 92
Elevated sweat chloride test: is it always cystic fibrosis 92
Can Continuous Subcutaneous Insulin Infusion Improve Health-Related Quality of Life in Patients with Shwachman-Bodian-Diamond Syndrome and Diabetes? 91
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis. 91
The Italian pilot external quality assessment program for cystic fibrosis sweat test 91
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial 91
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. 91
Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying 89
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 89
Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis 88
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life 88
Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study) 87
Aspergillosi broncopolmonare 87
Morphological method for the diagnosis of human adult type hypolactasia 86
Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis 86
Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis 86
Defective proteostasis in celiac disease as a new therapeutic target 86
Cystic fibrosis: A disorder with defective autophagy 86
Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect. 84
Chryseobacterium respiratory tract infections in patients with cystic fibrosis. 83
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. 83
Liver expression in cystic fibrosis could be modulated by genetic factors from the cystic fibrosis transmembrane regulator genotype 82
The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated 82
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution 82
Genetic modifiers of liver disease in cystic fibrosis. 82
Amines Protect Invitro the Celiac Small-intestine From the Damaging Activity of Gliadin Peptides 82
Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function. 82
Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration 81
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia 81
Sphingobacterium respiratory tract infection in patients with cystic fibrosis. 81
Audit of sweat testing: a first report from Italian Cystic Fibrosis Centres 80
PFGE and antibiotic susceptibility phenothype analysis of Pseudomonas aeruginosa strain chronically infecting Cystic Fibrosis patients. 80
Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations 79
Liver expression in Cystic Fibrosis could be modulated by genetic factors different from the Cystic Fibrosis Transmembrane Regulator genotype. 78
Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry 78
Laparoscopy-guided biopsy in diagnosis of liver disorders in children. 76
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients. 76
7. An overview of international literature from cystic fibrosis registries. Part 4: update 2011 76
Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. 76
Totale 10.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 76 54 9 80 12 102 29
2021/20221.038 17 5 5 0 0 158 18 41 108 58 219 409
2022/20231.220 195 122 26 77 139 125 4 122 189 149 55 17
2023/2024875 25 113 167 75 50 100 31 61 15 27 156 55
2024/20254.659 244 359 14 51 95 226 541 325 322 435 1.659 388
2025/20265.587 976 651 934 1.007 1.715 304 0 0 0 0 0 0
Totale 15.185